Article

Synthesis and characterization of cytidine derivatives that inhibit the kinase IspE of the non-mevalonate pathway for isoprenoid biosynthesis.

Laboratorium für Organische Chemie, ETH Zürich, HCI, CH-8093 Zürich, Switzerland.
ChemMedChem (Impact Factor: 3.05). 02/2008; 3(1):91-101. DOI: 10.1002/cmdc.200700208
Source: PubMed

ABSTRACT The enzymes of the non-mevalonate pathway for isoprenoid biosynthesis are attractive targets for the development of novel drugs against malaria and tuberculosis. This pathway is used exclusively by the corresponding pathogens, but not by humans. A series of water-soluble, cytidine-based inhibitors that were originally designed for the fourth enzyme in the pathway, IspD, were shown to inhibit the subsequent enzyme, the kinase IspE (from Escherichia coli). The binding mode of the inhibitors was verified by co-crystal structure analysis, using Aquifex aeolicus IspE. The crystal structures represent the first reported example of a co-crystal structure of IspE with a synthetic ligand and confirmed that ligand binding affinity originates mainly from the interactions of the nucleobase moiety in the cytidine binding pocket of the enzyme. In contrast, the appended benzimidazole moieties of the ligands adopt various orientations in the active site and establish only poor intermolecular contacts with the protein. Defined binding sites for sulfate ions and glycerol molecules, components in the crystallization buffer, near the well-conserved ATP-binding Gly-rich loop of IspE were observed. The crystal structures of A. aeolicus IspE nicely complement the one from E. coli IspE for use in structure-based design, namely by providing invaluable structural information for the design of inhibitors targeting IspE from Mycobacterium tuberculosis and Plasmodium falciparum. Similar to the enzymes from these pathogens, A. aeolicus IspE directs the OH group of a tyrosine residue into a pocket in the active site. In the E. coli enzyme, on the other hand, this pocket is lined by phenylalanine and has a more pronounced hydrophobic character.

Download full-text

Full-text

Available from: Adelbert Bacher, Jun 23, 2015
0 Followers
 · 
158 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Structure-based ligand design in medicinal chemistry and crop protection relies on the identification and quantification of weak noncovalent interactions and understanding the role of water. Small-molecule and protein structural database searches are important tools to retrieve existing knowledge. Thermodynamic profiling, combined with X-ray structural and computational studies, is the key to elucidate the energetics of the replacement of water by ligands. Biological receptor sites vary greatly in shape, conformational dynamics, and polarity, and require different ligand-design strategies, as shown for various case studies. Interactions between dipoles have become a central theme of molecular recognition. Orthogonal interactions, halogen bonding, and amide⋅⋅⋅π stacking provide new tools for innovative lead optimization. The combination of synthetic models and biological complexation studies is required to gather reliable information on weak noncovalent interactions and the role of water.
    Angewandte Chemie International Edition 01/2015; 46(18). DOI:10.1002/anie.201408487 · 11.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: b] and François Diederich* [a] Keywords: Drug design / Inhibitors / Ligand design / Molecular recognition The enzymes of the mevalonate-independent biosynthetic pathway to isoprenoids are attractive targets for the develop-ment of new drug candidates, in particular against malaria and tuberculosis, because they are present in major human pathogens but not in humans. Herein, the structure-based design, synthesis, and biological evaluation of a series of in-hibitors featuring a central imidazole or benzimidazole scaf-fold for the kinase IspE from E. coli, a model for the corre-sponding malarial enzyme, are described. Optimization of the binding preferences of the hydrophobic sub-pocket at the substrate-binding site allowed IC 50 values in the lower micromolar range to be reached. Structure–activity relation-ship studies using a 1,2-disubstituted imidazole central core revealed that alicyclic moieties fit the sub-pocket better than
  • [Show abstract] [Hide abstract]
    ABSTRACT: The first five steps of the non-mevalonate pathway have been tested in high-throughput screening (HTS) campaigns, using enzymes of plant origin. Hit rates were in general relatively low, which could be attributed to the high polarity and charged nature of substrates and active sites of these enzymes. Still, for all the enzymes, apart from IspF (2-methylerythritol 2,4-cyclodiphosphate synthase), inhibitors could be identified with activities below 100 μM, and these were followed up to identify structure-activity relationships (SARs). For the enzyme IspD (2C-methyl-D-erythritol 4-phosphate cytidyltransferase), inhibitors with IC50 down to 35 nM were identified that also showed herbicidal activity.
    Pest Management Science 05/2013; 69(5). DOI:10.1002/ps.3479 · 2.74 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Structure-based ligand design in medicinal chemistry and crop protection relies on the identification and quantification of weak noncovalent interactions and understanding the role of water. Small-molecule and protein structural database searches are important tools to retrieve existing knowledge. Thermodynamic profiling, combined with X-ray structural and computational studies, is the key to elucidate the energetics of the replacement of water by ligands. Biological receptor sites vary greatly in shape, conformational dynamics, and polarity, and require different ligand-design strategies, as shown for various case studies. Interactions between dipoles have become a central theme of molecular recognition. Orthogonal interactions, halogen bonding, and amide⋅⋅⋅π stacking provide new tools for innovative lead optimization. The combination of synthetic models and biological complexation studies is required to gather reliable information on weak noncovalent interactions and the role of water.
    Angewandte Chemie International Edition 01/2015; 46(18). DOI:10.1002/anie.201408487 · 11.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: b] and François Diederich* [a] Keywords: Drug design / Inhibitors / Ligand design / Molecular recognition The enzymes of the mevalonate-independent biosynthetic pathway to isoprenoids are attractive targets for the develop-ment of new drug candidates, in particular against malaria and tuberculosis, because they are present in major human pathogens but not in humans. Herein, the structure-based design, synthesis, and biological evaluation of a series of in-hibitors featuring a central imidazole or benzimidazole scaf-fold for the kinase IspE from E. coli, a model for the corre-sponding malarial enzyme, are described. Optimization of the binding preferences of the hydrophobic sub-pocket at the substrate-binding site allowed IC 50 values in the lower micromolar range to be reached. Structure–activity relation-ship studies using a 1,2-disubstituted imidazole central core revealed that alicyclic moieties fit the sub-pocket better than
  • [Show abstract] [Hide abstract]
    ABSTRACT: The first five steps of the non-mevalonate pathway have been tested in high-throughput screening (HTS) campaigns, using enzymes of plant origin. Hit rates were in general relatively low, which could be attributed to the high polarity and charged nature of substrates and active sites of these enzymes. Still, for all the enzymes, apart from IspF (2-methylerythritol 2,4-cyclodiphosphate synthase), inhibitors could be identified with activities below 100 μM, and these were followed up to identify structure-activity relationships (SARs). For the enzyme IspD (2C-methyl-D-erythritol 4-phosphate cytidyltransferase), inhibitors with IC50 down to 35 nM were identified that also showed herbicidal activity.
    Pest Management Science 05/2013; 69(5). DOI:10.1002/ps.3479 · 2.74 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Structure-based ligand design in medicinal chemistry and crop protection relies on the identification and quantification of weak noncovalent interactions and understanding the role of water. Small-molecule and protein structural database searches are important tools to retrieve existing knowledge. Thermodynamic profiling, combined with X-ray structural and computational studies, is the key to elucidate the energetics of the replacement of water by ligands. Biological receptor sites vary greatly in shape, conformational dynamics, and polarity, and require different ligand-design strategies, as shown for various case studies. Interactions between dipoles have become a central theme of molecular recognition. Orthogonal interactions, halogen bonding, and amide⋅⋅⋅π stacking provide new tools for innovative lead optimization. The combination of synthetic models and biological complexation studies is required to gather reliable information on weak noncovalent interactions and the role of water.
    Angewandte Chemie International Edition 01/2015; 46(18). DOI:10.1002/anie.201408487 · 11.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: b] and François Diederich* [a] Keywords: Drug design / Inhibitors / Ligand design / Molecular recognition The enzymes of the mevalonate-independent biosynthetic pathway to isoprenoids are attractive targets for the develop-ment of new drug candidates, in particular against malaria and tuberculosis, because they are present in major human pathogens but not in humans. Herein, the structure-based design, synthesis, and biological evaluation of a series of in-hibitors featuring a central imidazole or benzimidazole scaf-fold for the kinase IspE from E. coli, a model for the corre-sponding malarial enzyme, are described. Optimization of the binding preferences of the hydrophobic sub-pocket at the substrate-binding site allowed IC 50 values in the lower micromolar range to be reached. Structure–activity relation-ship studies using a 1,2-disubstituted imidazole central core revealed that alicyclic moieties fit the sub-pocket better than
  • [Show abstract] [Hide abstract]
    ABSTRACT: The first five steps of the non-mevalonate pathway have been tested in high-throughput screening (HTS) campaigns, using enzymes of plant origin. Hit rates were in general relatively low, which could be attributed to the high polarity and charged nature of substrates and active sites of these enzymes. Still, for all the enzymes, apart from IspF (2-methylerythritol 2,4-cyclodiphosphate synthase), inhibitors could be identified with activities below 100 μM, and these were followed up to identify structure-activity relationships (SARs). For the enzyme IspD (2C-methyl-D-erythritol 4-phosphate cytidyltransferase), inhibitors with IC50 down to 35 nM were identified that also showed herbicidal activity.
    Pest Management Science 05/2013; 69(5). DOI:10.1002/ps.3479 · 2.74 Impact Factor